The NMA generated 66 direct or indirect comparisons, 5 of which were statistically significant, while the remaining were not, as shown in Figure 4A. SUCRA results show that, in terms of ranking probability, EA has the highest cumulative probability (SUCRA: 86%), making it the best intervention to improve FSH in patients with PCOS (Figure S1A, Supplemental Digital Content, https://links.lww.com/MD/Q404). This evidence concerns the gene BRD2 and polycystic ovary syndrome.